Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences and Genzyme Genetics Cross-License Patents

NEW YORK, May 7 -- Exact Sciences of Maynard, Mass., and Genzyme Genetics, a subsidiary of Genzyme General, today announced the signing of a cross-license and collaboration agreement covering 15 technology patents.

 

Financial details were not disclosed. Both companies have contributed equally to the patent pool, an Exact company spokeswoman told GenomeWeb.

 

Exact and Genzyme Genetics will collaborate on the development of molecular diagnostics for hematologic oncology.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.